Local immune response may be important in defense against urinary tract infection (UTI). P fimbria, an important virulence factor of Escherichia coli, is a noteworthy candidate for use in a vaccine against pyelonephritis (PN). Eleven patients with PN and 14 patients with lower urinary tract infection (LUTI) caused by E. coli were studied for mucosa-derived antibody-secreting cells (ASCs) and for urinary antibodies. In the 10 patients with P-fimbriated (P+) E. coli, an ASC response to P fimbria was found in 5 of 5 patients who had PN and 1 of 5 patients who had LUTI. The response to P fimbria was stronger among patients with P+ PN than among patients with PN caused by non-P-fimbriated E. coli (P-) (P
CITATION STYLE
Kantele, A., Möttönen, T., Ala-Kaila, K., & Arvilommi, H. S. (2003). P Fimbria-Specific B Cell Responses in Patients with Urinary Tract Infection. Journal of Infectious Diseases, 188(12), 1885–1891. https://doi.org/10.1086/380097
Mendeley helps you to discover research relevant for your work.